| Olufunke Oyeronke Adetunji, LCPC | |
|
402 Armstrong Ct Apt A, Laurel, MD 20707-5124 | |
| (240) 291-8313 | |
| Not Available |
| Full Name | Olufunke Oyeronke Adetunji |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 402 Armstrong Ct Apt A, Laurel, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023459187 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | LC4175 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Olufunke Oyeronke Adetunji, LCPC 402 Armstrong Ct Apt A, Laurel, MD 20707-5124 Ph: (240) 291-8313 | Olufunke Oyeronke Adetunji, LCPC 402 Armstrong Ct Apt A, Laurel, MD 20707-5124 Ph: (240) 291-8313 |
News Archive
Award-winning UK manufacturer of innovative and high quality single-use surgical instruments DTR Medical, will showcase its new Bone Trephine product at MEDICA - the world's largest medical trade fair.
AllTranz, Inc., a specialty pharmaceutical company focused on developing drugs to treat a variety of neurologic and inflammatory disorders, today announced that it has been awarded a $4 million research grant from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to advance the company's transdermal tetrahydrocannabinol (THC) patch for the treatment of marijuana dependence and withdrawal.
Intralign Health, LLC, a specialty healthcare services provider, announced today that it has signed a physician participation agreement with CareFirst BlueCross BlueShield, a not-for-profit health insurer serving approximately 3.4 million individuals. The agreement allows Surgical First Assistants (SFAs) in-network status for their support of surgeons in Maryland hospitals.
Peripheral arterial disease is a common circulation problem in which reduced blood flow can lead to complications that jeopardize the limbs, possibly even requiring amputation. Procedures known as revascularization have reduced the need for amputations 40 percent over two decades, Mayo Clinic research shows.
Onconova Therapeutics, Inc., a development-stage pharmaceutical company focused on discovering and developing novel small molecule drug products to treat cancer, today announced that tolerability and favorable anti-tumor activity data from a Phase 1 trial evaluating oral rigosertib, a dual pathway inhibitor, in patients with advanced solid tumors including refractory metastatic head and neck cancer were presented today at the American Association for Cancer Research Annual Meeting.
› Verified 4 days ago
Tenesha Renae Jeffery, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3446 Andrew Ct Apt 301, Laurel, MD 20724 Phone: 202-834-2187 | |
Mekedes Dagnachew Legesse, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 14502 Greenview Dr Ste 202, Laurel, MD 20708 Phone: 240-581-1500 Fax: 240-513-4122 | |
Desiree Deville, LMSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 531 Main St, Laurel, MD 20707 Phone: 240-451-2171 | |
Ms. Diane H. Wilson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 9212 Fairlane Pl, Laurel, MD 20708 Phone: 240-568-9313 Fax: 410-605-7731 | |
Mr. Robert Louis Smith, Counselor Medicare: Not Enrolled in Medicare Practice Location: 4200 Somerville Ct, Laurel, MD 20708 Phone: 301-210-3468 Fax: 301-210-3478 | |
Femi Scott, Counselor Medicare: Not Enrolled in Medicare Practice Location: 9445 Fens Holw, Laurel, MD 20723 Phone: 240-716-8571 | |
Chrity Nsude, Counselor Medicare: Not Enrolled in Medicare Practice Location: 14300 Cherry Lane Ct Ste 202-203, Laurel, MD 20707 Phone: 240-360-2637 |